Pomerantz LLP is investigating claims on behalf of investors of Credit Suisse Group A.G. ("Credit Suisse" or the "Company") (NYSE: CS). Such investors are advised to contact Robert S. Willoughby at firstname.lastname@example.org or 888-476-6529, ext. 9980.
The investigation concerns whether Credit Suisse and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
On February 4, 2016, Credit Suisse announced its Fourth Quarter and Full Year 2015 financial results, which included a massive $633 million write-down from the sale of the Bank's outsized, illiquid distressed debt and CLO positions, an incredible loss that would swell to nearly $1 billion in the ensuing weeks. In the wake of Credit Suisse's revelations, the price of the Bank's ADRs declined from a close of $16.69 on February 3, 2016 to a close of $14.89 on February 4, 2016, an 11% drop that wiped out approximately $230 million in market capitalization.